Summit Therapeutics Inc. SMMT
$13.85
▲ +7.11% 24H
About
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicinal therapies designed to be patient, physician, caregiver, and societally friendly. Its lead candidate, ivonescimab, is a first-in-class bispecific antibody that simultaneously targe…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees265
TickerSMMT
Statistics
Market Cap$10.75B
Revenue (TTM)—
Net Income-$1.08B
Net Margin—
EPS$-1.44
P/E25.02
P/S—
P/B18.58
EV/EBITDA-7.83
ROE-271.0%
Dividend Yield—
Price$13.85
Data: Twelve Data · Revenue = mcap / P/S